GLP-1 Medications for Weight Loss: Complete Guide 2024

You've counted calories. You've meal-prepped on Sundays. You've tried the elimination diets, the HIIT programs, the intermittent fasting schedules — and still, the scale barely moves. If this sounds like your story, you're not alone, and you're not doing anything wrong. For millions of women, the struggle with weight loss has always been framed as a willpower problem. But the science now tells us something very different: your biology has been working against you, and there's finally a class of medication designed to work with it.

GLP-1 medications for weight loss have fundamentally changed the conversation about what effective, sustainable weight management actually looks like. This guide is the resource we wish every woman had before making a decision — honest, thorough, and built around your body, not a one-size-fits-all protocol. We'll walk through exactly what GLP-1 medications are, how they work, who they're right for, what realistic results look like, and what you need to know about safety.

At Amie, we help women access this class of medication through a physician-led telehealth experience designed specifically for the way women's bodies work — because you deserve more than a generic prescription. You deserve a plan.

GLP-1 Medications 101: What They Are and Why Everyone's Talking About Them

The Science Behind the Name (Without the Jargon)

GLP-1 stands for glucagon-like peptide-1 — a hormone your gut naturally produces after you eat. In plain terms, GLP-1 does three things: it tells your brain you're full, it slows the rate at which food leaves your stomach, and it signals your pancreas to release insulin when your blood sugar rises.

GLP-1 receptor agonists are medications that mimic and amplify this hormone's effects. Think of them as turning up the volume on a signal your body already uses — just one that may not be loud enough on its own. Research published in Nature Reviews Endocrinology has shown that people with obesity often have reduced GLP-1 secretion or impaired incretin response, which may contribute to persistent hunger and weight-loss resistance.

If you're curious about the broader hormone system behind this, our guide on incretin hormones and weight management goes deeper.

From Diabetes Drug to Weight Loss Breakthrough — A Brief History

GLP-1 receptor agonists were originally developed to treat Type 2 diabetes. Early medications like exenatide and liraglutide helped diabetic patients control blood sugar — but researchers kept noticing a consistent "side effect": significant weight loss.

That observation led to dedicated weight-loss trials. In June 2021, the FDA approved semaglutide (sold as Wegovy) specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Then in late 2023, tirzepatide (Zepbound) — a next-generation dual GLP-1/GIP agonist — received its own weight management approval. The field has moved fast, and the data behind these medications is among the strongest ever seen for prescription weight loss.

For a deeper look at the newest option, read our guide on tirzepatide and how the dual-agonist mechanism works.

How GLP-1 Medications Actually Work for Weight Loss

The Four Key Mechanisms

GLP-1 medications don't work through a single trick. They act on multiple systems simultaneously, which is a big part of why they're so effective:

• Appetite regulation: GLP-1 agonists act directly on the hypothalamus — the brain's hunger control center — to reduce hunger signals. You feel genuinely satisfied with less food, and cravings quiet down noticeably.
• Slowed gastric emptying: Food stays in your stomach longer, which extends feelings of fullness after meals. That "I could eat again in an hour" feeling? It fades.
• Blood sugar stabilization: By improving insulin response and reducing post-meal glucose spikes, GLP-1s help prevent the crash-and-craving cycle that drives so much overeating — a cycle women with insulin resistance know intimately.
• Reduced "food noise": Emerging research suggests GLP-1 agonists may also quiet the constant mental preoccupation with food that many patients describe. This effect is still being studied, but patient reports are remarkably consistent. A 2023 study in Obesity (Silver Spring) found that semaglutide significantly reduced food cravings and preoccupation with eating compared to placebo.

For a detailed breakdown of each mechanism, see how GLP-1 agonists work for weight loss in women and our guide on GLP-1's effects on blood sugar and weight loss.

Why This Is Different From "Just Eating Less"

Here's the reframe that matters: GLP-1 medications don't impose willpower. They restore biological signaling that may have been impaired for years — or decades.

Think of it this way. Telling someone with blurry vision to "just try harder to see" would be absurd. You'd give them glasses. GLP-1 medications work similarly: they correct a physiological gap between how your body signals hunger and how you're able to respond to those signals. Your hunger has always been real. Your struggle has always been biological, not a character flaw. And now there's a medical tool that matches the science.

GLP-1 Medications Compared: Every Option Available in 2024

The GLP-1 medication class has expanded significantly. Here's a clear comparison of every major option available right now, including the best GLP-1 medications for women in 2024.

*All percentage figures represent clinical trial averages (STEP and SURMOUNT trial programs). Individual results vary based on dose, adherence, lifestyle factors, and starting weight. These are not guaranteed outcomes.

Semaglutide (Ozempic / Wegovy)

Semaglutide is the medication that brought GLP-1s into the mainstream. Ozempic is FDA-approved for Type 2 diabetes and is widely prescribed off-label for weight loss. Wegovy is the same active ingredient at a higher dose, approved specifically for chronic weight management. In the landmark STEP 1 trial, published in the New England Journal of Medicine, participants taking semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks — compared to 2.4% with placebo.

For a full breakdown of this medication, read What Is Semaglutide? Our Complete GLP-1 Weight Loss Guide.

Tirzepatide (Mounjaro / Zepbound)

Tirzepatide works on two receptor pathways — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) — which is why it's called a dual agonist. Zepbound received FDA approval for weight management in November 2023. In the SURMOUNT-1 trial, participants on the highest dose lost an average of 20.9% of their body weight over 72 weeks. That's the strongest clinical result ever seen for a weight-loss medication. Our semaglutide vs. tirzepatide comparison covers the differences in detail.

Liraglutide (Victoza / Saxenda)

Liraglutide is the older generation GLP-1 agonist. Saxenda is its weight-loss formulation, requiring a once-daily injection rather than weekly dosing. Average weight loss is lower than semaglutide — typically 5–8% of body weight — and the daily injection schedule is less convenient. That said, it remains a valid option for certain patients. See our semaglutide vs. liraglutide guide for a full comparison.

Compounded Semaglutide

Compounded semaglutide contains the same active ingredient as Wegovy and Ozempic, prepared by licensed compounding pharmacies — often at significantly more accessible price points than brand-name versions. Some formulations include supportive additions like vitamin B12. During periods of brand-name shortage, compounded semaglutide has become an important access point for patients who would otherwise go without treatment.

The key: sourcing matters enormously. You want a compounded medication prescribed by a licensed physician and dispensed by a regulated, 503A or 503B pharmacy. Learn more in our guide to compounded vs. brand-name semaglutide and our full analysis of the differences.

Why GLP-1 Medications Work Differently for Women

Most GLP-1 guides treat weight loss as gender-neutral. It isn't. Women's bodies store, gain, and lose weight through mechanisms deeply tied to hormonal fluctuations — and understanding that connection changes how you should think about medical weight management.

Hormonal Weight Gain Is Real — And GLP-1s Address It Differently

Estrogen, progesterone, cortisol, and insulin don't just affect your menstrual cycle — they directly control where your body stores fat, how hungry you feel, and how efficiently you burn calories. During perimenopause and menopause, declining estrogen triggers a shift in fat distribution toward visceral (abdominal) fat, even when diet and exercise haven't changed. Insulin resistance also increases during this transition, creating a metabolic environment that actively promotes weight gain.

GLP-1 medications help address several of these metabolic changes simultaneously: improving insulin sensitivity, reducing appetite driven by hormonal hunger signals, and supporting weight loss in areas where hormonal shifts have made it hardest. They don't treat hormonal imbalance directly, but they work alongside the metabolic reality women in midlife are facing. Read more about the signs of hormonal weight gain and the perimenopause connection.

The Perimenopause + GLP-1 Combination Worth Knowing About

Women in their 40s and 50s are often dealing with a double challenge: hormonal shifts and metabolic weight-loss resistance at the same time. GLP-1 therapy and hormonal support can work complementarily — not as replacements for one another, but as parts of a broader approach that actually accounts for what's happening in your body.

For women experiencing hot flashes, mood changes, and hormonal symptoms alongside metabolic challenges, Amie's Grace supplement offers OTC support for hormonal balance — a natural complement to a medical weight loss program. And for women focused on energy and cellular health during this transition, our NAD+ therapy supports recovery and vitality at the cellular level.

What the Clinical Research Actually Shows for Women

The major GLP-1 clinical trials — including STEP (semaglutide) and SURMOUNT (tirzepatide) — enrolled large female populations, so the efficacy data is well-represented for women. Some clinical observations worth noting: women may experience nausea more frequently or intensely during dose titration, and women with lower starting body weights may notice that dosing adjustments feel more significant. These aren't reasons for concern — they're reasons why working with a provider who understands female physiology matters.

For a deeper look at how slow metabolism connects to GLP-1 therapy, we've covered that too.

Is GLP-1 Treatment Right for You? Who's a Good Candidate

The Clinical Criteria Providers Look For

The FDA guidelines for GLP-1 prescriptions for weight management are straightforward:

• BMI of 30 or above (obesity), or
• BMI of 27 or above with at least one weight-related health condition — such as hypertension, Type 2 diabetes, high cholesterol, or sleep apnea

Your provider will also review your medical history, current medications, thyroid health, and family history of certain conditions (including medullary thyroid carcinoma). This evaluation is a standard and important part of the process. Learn more about signs you may be a good candidate.

Signs You May Benefit Beyond the BMI Number

The clinical criteria are the starting point, but your lived experience matters too. You may especially benefit from GLP-1 therapy if you:

• Have struggled with weight despite consistent diet and exercise efforts
• Experience intense, difficult-to-control food cravings — especially for carbohydrates or sugar
• Have been told you have insulin resistance or prediabetes (here are the signs)
• Gained weight that accelerated during perimenopause, postpartum, or after hormonal changes
• Feel emotionally and mentally exhausted from years of yo-yo dieting

If you've been questioning whether medical weight loss is the right next step vs. diet alone, that article can help clarify the decision.

GLP-1 Weight Loss Results: Realistic Timelines and What to Expect

One of the most common questions we hear: how fast will this work? Here's the honest, week-by-week picture — because setting realistic expectations is one of the best things you can do for your long-term success.

The First 4 Weeks: The Adjustment Phase

You'll start at a low dose — this is called the titration period, and it's intentional. Starting low allows your body to adjust and minimizes side effects. Most women notice appetite changes within the first one to two weeks: portions feel more satisfying, snacking urges decrease, and the mental "pull" toward food loosens slightly.

Scale movement in the first month is typically modest — 2 to 5 pounds for most women. This is not a sign that the medication isn't working. It's a sign that the dose is building properly. Patience here protects you later.

Weeks 4–12: The Momentum Phase

This is where most women feel the shift. Your dose typically increases during this window, and the appetite-suppressing and craving-reducing effects deepen noticeably. Weight loss becomes more consistent and measurable. The "food noise" reduction — that constant background hum of thinking about your next meal — is what patients most often describe as life-changing.

Our guide on how long semaglutide takes to work covers this timeline in detail, including the signs your GLP-1 medication is working.

3–12 Months: Sustainable Loss

According to the STEP 1 trial data published in the New England Journal of Medicine, participants taking semaglutide 2.4 mg achieved an average of 14.9% body weight reduction at 68 weeks. The SURMOUNT-1 trial for tirzepatide showed up to 20.9% average reduction at 72 weeks. The most significant, visible changes happen between months 3 and 12 for most patients.

During this phase, we encourage tracking non-scale victories alongside the number: energy levels, sleep quality, blood sugar markers, how your clothing fits, and how you feel in your body. These metrics often tell a richer story than the scale alone. For practical guidance, see how to track progress on GLP-1 treatment and how to maximize your results.

Side Effects, Safety, and What to Watch For

No honest guide skips this section. GLP-1 medications have a strong safety profile — they've been studied in trials involving tens of thousands of participants — but they do come with side effects, especially during dose titration.

Common Side Effects

The most frequently reported side effects are gastrointestinal:

• Nausea — the most common side effect, especially in the first few weeks. It typically improves as your body adjusts and responds well to the slow-titration approach.
• Constipation or diarrhea — GI motility changes as gastric emptying slows.
• Decreased appetite — this is technically the intended effect, but it can feel unfamiliar at first.
• Mild injection site reactions — redness, minor bruising, or itching at the injection site.
• Fatigue or headache — less common, usually temporary during the first few dose increases.

Most of these side effects are dose-dependent and temporary. Eating smaller meals, staying hydrated, and following your provider's titration schedule are the best strategies. Our expert strategies for managing GLP-1 side effects covers this in depth, and our full GLP-1 side effects safety guide covers the rare and serious considerations.

Serious Side Effects (Rare but Important)

In rare cases, GLP-1 medications have been associated with:

• Pancreatitis (seek medical attention for severe, persistent abdominal pain)
• Gallbladder issues, including gallstones (more likely with rapid weight loss)
• Thyroid C-cell tumors — observed in rodent studies at high doses. The clinical relevance in humans is still being studied, but GLP-1s carry a boxed warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma.

This is exactly why physician oversight matters. GLP-1 medications should always be prescribed and monitored by a licensed provider who reviews your full health history — not purchased from unregulated sources online.

GLP-1 vs. Other Weight Loss Methods: How They Compare

GLP-1 medications didn't emerge in a vacuum. Here's how they compare to other common approaches — because context helps you make the best decision for your body.

Individual results vary across all methods. The right approach depends on your medical history, goals, and provider guidance.

GLP-1 medications occupy a unique space: they deliver meaningful, clinically significant weight loss without surgery, they address biological hunger and metabolic function rather than relying on restriction alone, and they have strong clinical trial evidence behind them. For many women, they fill the gap between "I've tried everything" and "I'm not ready for surgery."

For a deeper comparison, read how GLP-1 treatment compares to other weight loss methods, GLP-1 vs. traditional diet pills, and GLP-1 vs. gastric bypass.

Supporting Your GLP-1 Results: The Full Picture

GLP-1 medications are powerful, but they work best as part of a broader approach. The women who see the strongest, most lasting results pair their medication with intentional lifestyle support.

Nutrition and Movement

Because GLP-1s reduce appetite significantly, the quality of what you eat matters more than ever. Protein intake becomes especially important — it supports lean muscle preservation during weight loss, which protects your metabolism long-term. Your provider or a registered dietitian can help you build a nutrition plan that works with your medication, not around it.

Movement doesn't have to mean intense gym sessions. Resistance training, walking, and consistent moderate activity all support body composition changes and improve how you feel throughout treatment.

Complementary Therapies

Depending on your health goals and where you are in life, additional support can amplify your results:

• Hormonal support: For women in perimenopause or menopause, addressing hot flashes, mood, and sleep with Amie's Grace supplement can help you feel more like yourself while your body composition changes.
• Cellular energy:NAD+ therapy supports mitochondrial function, energy production, and recovery — especially valuable during active weight loss.
• Body composition optimization:Sermorelin therapy supports growth hormone release, which can improve lean body mass, recovery, and vitality — a meaningful complement for women focused on body composition, not just the scale.

For practical tips on building a support system around your treatment, read how to maximize your GLP-1 weight loss results.

How to Get Started With GLP-1 Medications

If you've read this far and you're thinking this might be right for me, here's what the process actually looks like — especially through a telehealth platform like Amie.

1. Complete a medical intake. You'll answer questions about your health history, current medications, weight-loss history, and goals. This takes about 10–15 minutes.
2. Meet with a licensed provider. A physician reviews your information, discusses your options, and determines whether GLP-1 therapy is appropriate and safe for you. At Amie, this is a real provider conversation — not an automated approval.
3. Receive your prescription. If approved, your prescription is sent to a licensed compounding pharmacy and shipped directly to you.
4. Begin treatment with ongoing support. You'll start at a low dose and follow a titration schedule with provider check-ins. Questions, side effect management, and dose adjustments are all handled by your care team.

For a step-by-step walkthrough, see our complete beginner's guide to starting GLP-1 medication and our injection tutorial.

Frequently Asked Questions About GLP-1

GLP-1Weight LossMetabolic HealthTreatments

Share

Written by

Dr. Sarah Mitchell, MD

MD

Dr. Kim combines conventional medicine with holistic approaches to women's health. She specializes in menopause management, hormone balance, and longevity medicine.

Medically Reviewed by

Dr. Sarah Mitchell, MD

MD

Last reviewed: March 23, 2026

NPI: 1679815096